Big companies are getting smaller, and their CEOs want everyone to know it. Wells Fargo has cut its workforce by 23% over five years, Bank of America has shed 88,000 employees since 2010, and Verizon’s CEO recently boasted that headcount is “going down all the time.” What was once a sign of corporate distress has become a badge of honor, with executives celebrating lean operations and AI-driven
Novartis Nabs FDA Approval for First-of-Its-Kind Drug for Chronic Hives
Novartis drug Rhapsido is now approved as a second-line treatment for chronic spontaneous urticaria, a rare inflammatory skin disease. Additional clinical trials are ongoing to
